Engimmune Therapeutics Raises Chf 15.5 Million In Seed Financing To Develop Novel T-Cell Receptor Therapeutics
Round Type
Seed
BaselBiotechnologyData And AnalyticsHealth CareScience And EngineeringArtificial IntelligenceDescription
Engimmune Therapeutics AG ("Engimmune"), a Swiss biotech company developing novel T-cell receptor (TCR)-based therapeutics, announced today the completion of a CHF 15.5 million (EUR 15.2 m / USD 16.7 m) seed financing round, co-led by Pureos Bioventures and Novo Holdings.
Quick answer
Engimmune Therapeutics raised an undisclosed amount in a Seed round, dated May 3, 2022. Engimmune Therapeutics is based in Basel, Basel City, Switzerland.
- How much did Engimmune Therapeutics raise?
- Engimmune Therapeutics raised an undisclosed amount in a Seed round on May 3, 2022.
- What does Engimmune Therapeutics do?
- Engimmune is an immunotherapy company utilising cutting-edge methods for the development of T-cell receptor (TCR)-based immunotherapies including T cell therapies and biologics.
- Where is Engimmune Therapeutics based and how big is it?
- Engimmune Therapeutics is based in Basel, Basel City, Switzerland.
- Who are the decision-makers at Engimmune Therapeutics?
- Fundz holds 1 contact at Engimmune Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Data And Analytics and Science And Engineering around the same time
Companies in the same sectors as Engimmune Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- IMPLICITY raised $23M (Funding Round) on April 27, 2022.
- Unlearn raised $50M (Series B) on April 19, 2022.
- Unlearn raised $50M on April 19, 2022.
- Zephyr AI, Inc. raised $18M on April 4, 2022.
- Zephyr AI, Inc. raised $19M (Seed) on March 30, 2022.
- Nucleai raised $33M (Series B) on March 22, 2022.
Who to call at Engimmune Therapeutics, and when
A new round usually means Engimmune Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Engimmune Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Engimmune Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Engimmune Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Engimmune Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Engimmune Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.